Difference between revisions of "DZI20-199-Case-7"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 75: Line 75:
 
|subject=Z0FBQUFBQmYxUUtzdUc2MVdxcGsxbFpoWlpybXczZFh4NXlYeDUxbGZIRTZxTVJaNlpwSEZ6RExHQTl4ZGhPblFuSEVlUFNQUVRmWEpiWWNMdUtENnhnX3lMZEN3T0czVmc9PQ
 
|subject=Z0FBQUFBQmYxUUtzdUc2MVdxcGsxbFpoWlpybXczZFh4NXlYeDUxbGZIRTZxTVJaNlpwSEZ6RExHQTl4ZGhPblFuSEVlUFNQUVRmWEpiWWNMdUtENnhnX3lMZEN3T0czVmc9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Mjf79
 +
|authoredOn=December 12, 2020 05:45:21 PM
 
}}
 
}}

Latest revision as of 13:59, December 9, 2024

DZI20-199-Case-7
pancreas mass - whipple

FX1: bile duct margin FX2 + level: pancreatic transection margin (2nd and 3rd slides)

FX2A: mass (4th slide)
FX1 (bile duct margin): TINEM

FX2 (pancreatic transection margin): positive for carcinoma FX2A (mass): Positive for carcinoma

Permanent for part 2: Invasive adenocarcinoma with involved pancreatic transection margin
December 31, 1969 7:00:00 PM